Management of metallo-β-lactamase-producing Enterobacterales infections: a modified Delphi study
The Delphi panel reached consensus on optimal management of MBL-producing Enterobacterales, confirming need for targeted MBL treatment, with monotherapy preferred where available.
Authors
- P. Ramirez
- Maria Gheorghe (ORCID: https://orcid.org/0000-0002-4128-6063)
- Ana Cristina Gales
- Mengdi Wang (ORCID: https://orcid.org/0000-0002-2101-9507)
- Mark A Price
- Brett Hauber
- Ali S Omrani
- Stefan Hagel
- Andy Townsend
- Christopher John Little
- Marco Falcone
- Yehuda Carmeli
Institutions
- University of Pisa (IT)
- Pfizer (United States) (US)
- Pfizer (United Kingdom) (GB)
- National and Kapodistrian University of Athens (GR)
- Fudan University (CN)
- Tel Aviv Sourasky Medical Center (IL)
- Hospital Universitari i Politècnic La Fe (ES)
- Hamad General Hospital (QA)
- RTI Health Solutions (US)
- Jena University Hospital (DE)
- Huashan Hospital (CN)
- Manipal Hospital (IN)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1093/jacamr/dlag030
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer